Valuation Jaguar Health, Inc.

Stocks

Delayed Nasdaq Other stock markets 07:01:22 16/07/2026 pm IST			5-day change	1st Jan Change
1.920 ^USD	-1.54%		-18.99%	-94.11%

25/06	Jaguar Health, Inc., Napo Pharmaceuticals, Inc., And Woodward Specialty LLC Amend Manufacturing And Supply Agreement	CI
24/06	Jaguar Health Initiates Strategic-Alternatives Review Ahead of Crofelemer NDA Filing for Rare Intestinal Failure Program	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027
Market Cap ¹	45.04	13	7.678	11.92	4.225	1.176	-
Change	-	-71.13%	-40.94%	55.19%	-64.54%	-72.16%	-
Enterprise Value (EV) ¹	45.04	13	7.678	11.92	3.257	-1.57	-1.297
Change	-	-71.13%	-40.94%	55.19%	-72.67%	-148.2%	17.39%
P/E	-0.88x	-0.18x	-0.08x	-0.19x	-0.04x	-0.46x	-0.21x
PBR	-	-	-	-	-3.29x	0.06x	0.07x
PEG	-	0x	0x	0x	0x	0x	-0x
Capitalization / Revenue	10.4x	1.09x	-	1.02x	0.37x	0.06x	0.08x
EV / Revenue	10.4x	1.09x	-	1.02x	0.28x	-0.08x	-0.09x
EV / EBITDA	-	-	-	-	-0.07x	-0.38x	2.21x
EV / EBIT	-1.11x	-0.38x	-	-0.39x	-0.07x	-0.69x	0.52x
EV / FCF	-	-	-	-	-0.14x	-0.78x	0.36x
FCF Yield	-	-	-	-	-727%	-128%	277%
Dividend per Share ²	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-
EPS ²	-46,46,257	-18,99,448	-93,975	-4,574	-804	-4.2	-9.45
Distribution rate	-	-	-	-	-	-	-
Net sales ¹	4.335	11.96	-	11.69	11.51	20.46	14.11
EBITDA ¹	-	-	-	-	-44	4.157	-0.586
EBIT ¹	-40.71	-34.42	-	-30.83	-45.91	2.264	-2.477
Net income ¹	-52.6	-47.45	-41.3	-38.49	-53.58	-1.876	-5.517
Net Debt ¹	-	-	-	-	-0.968	-2.746	-2.473
Reference price ²	40,94,488.189	3,42,125.984	7,948.508	883.751	32.592	1.950	1.950
Nbr of stocks (in thousands)	0.01	0.04	0.97	13.5	130	603.1	-
Announcement Date	11/03/22	24/03/23	01/04/24	31/03/25	07/04/26	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
JAGUAR HEALTH, INC.	-0.46x	-0.08x	-0.38x	-	11.76L
ELI LILLY AND COMPANY	34.38x	12.29x	25.6x	0.58%	1,03100Cr
JOHNSON & JOHNSON	26.33x	6.06x	16.38x	2.17%	59TCr
ABBVIE INC.	30.03x	7.25x	14.87x	2.81%	43TCr
ROCHE HOLDING AG	17.64x	4.37x	10.78x	3.03%	33TCr
NOVARTIS AG	21.13x	5.43x	13.15x	2.91%	28TCr
ASTRAZENECA PLC	21.17x	4.46x	12.34x	1.97%	26TCr
NOVO NORDISK A/S	14.47x	5.42x	11.17x	3.43%	22TCr
AMGEN INC.	23.5x	6.23x	11.02x	2.81%	19TCr
GILEAD SCIENCES, INC.	-47.44x	5.68x	31.37x	2.46%	16TCr
Average	14.07x	5.71x	14.63x	2.47%	35.04TCr
Weighted average by Cap.	23.19x	7.66x	17.90x	2.04%